DDW® 2017 Telebriefing to Preview the Latest Research & Hot Topics

DDW® 2017 Telebriefing to Preview the Latest Research & Hot Topics

WHAT: A webinar media briefing with researchers to preview studies being presented at Digestive Disease Week® (DDW) 2017 in Chicago.

 WHO: Grace Elta, MDchair, DDW Council

            Winston Dunn, MD, associate professor, University of Kansas Medical Center, Kansas City

Reem Z. Sharaiha, MD, MSc, assistant professor, Weill Cornell Medical College, New York, NY

Keith Obstein, MD, MPH, associate professor, Vanderbilt University Medical Center, Nashville, TN

Julia König, PhD, post-doctoral research fellow, School of Medical Sciences at University of Örebro, Sweden

WHEN: Tuesday, April 25, 11 a.m. – noon ET

RSVP: Register now. If you have any problems accessing the registration link, please copy and paste the following URL into your browser: https://attendee.gotowebinar.com/register/1989111474294896641

Members of the media interested in receiving the embargoed news releases should contact Stephanie Wight, [email protected], (202) 868-4016. News releases are embargoed until the times indicated below.

Embargoed News Releases Available Upon Request

Selected studies include:

  • Study Identifies Genetic Markers That Could Improve Treatment of Hepatitis C

Winston Dunn, abstract Sa1535, embargoed until Saturday, May 6 at 9:30 a.m. CT

Hepatitis C (HCV)-associated cirrhosis is the most common indication for liver transplantation in U.S. adults. New research shows that genotyping of patients with advanced cirrhosis from HCV could help health-care professionals predict the likelihood of improvement after successful HCV treatment, thus minimizing the need for liver transplants.

  • Non-Surgical Weight-Loss Treatment Found Safe, Effective for Those with Limited Options

Reem Z. Sharaiha, abstract 334, embargoed until Saturday, May 5 at 11:54 a.m. CT

Obesity is the second-leading cause of preventable death, after tobacco use. A new study finds that individuals struggling with obesity who are not candidates for weight-loss surgery can benefit substantially from non-surgical endoscopic sleeve gastroplasty.

  • First-ever autonomously controlled “capsule robot” explores colon

Keith Obstein, abstract Mo1962, embargoed until Monday, May 8, at 9:30 a.m. CT

New research shows that an 18-mm magnetized capsule colonoscope, which can be paired with standard medical instruments, successfully and autonomously performed intricate maneuvers inside the colon while guided by an external magnet attached to a robotic arm. Researchers believe this technology will reduce the potential discomfort of colonoscopies and lead to more people undergoing the life-saving screening test.

  • A Unique Enzyme Could be a Game-Changer for Gluten-Sensitive Patients

Julia König, abstract Su1137, embargoed until Sunday, May 7, at 9:30 a.m. CT

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine. This could enable gluten-sensitive patients to ingest small quantities of gluten without experiencing symptoms, such as bloating, diarrhea and abdominal pain.


Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 6-9, 2017, at McCormick Place, Chicago. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org.

Follow us on Twitter @DDWMeeting; hashtag #DDW17. Become a fan of DDW on Facebook.